ROY DOUMANI Insider Trading $KITE Kite Pharma, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROY DOUMANI.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROY DOUMANI. ROY DOUMANI is Director in CTI MOLECULAR IMAGING INC ($CTMI) and Director in Kite Pharma, Inc. ($KITE).

ROY DOUMANI in Kite Pharma, Inc.

Trading Symbol: KITE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROY DOUMANI: Director
Holdings: 1,807 shares
Current Value: $96,349
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ROY DOUMANI in Kite Pharma, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CTMI, KITE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	D	91.21	8,810	803,560	0
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	D	50.87	7,000	356,090	0
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	D	59.23	10,000	592,300	0
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	D	6.89	30,000	206,700	0
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	U	180.00	25,065	4,511,700	0	25.1 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	D	0.00	1,807	0	0	1.8 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	U	180.00	150,620	27,111,600	1,807	152.4 K to 1.8 K (-98.81 %)
Jun 22 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	A	91.21	8,810	803,560	8,810
Jun 22 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Grant	A	0.00	2,410	0	152,427	150 K to 152.4 K (+1.61 %)
Jun 09 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	84.53	5,000	422,634	150,017	155 K to 150 K (-3.23 %)
Jun 09 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	84.46	10,000	844,621	155,017	165 K to 155 K (-6.06 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	M	1.35	50,000	67,500	75,065
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Buy	M	1.35	50,000	67,500	75,065	25.1 K to 75.1 K (+199.48 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	76.77	2,800	214,942	25,065	27.9 K to 25.1 K (-10.05 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	77.03	6,000	462,200	115,017	121 K to 115 K (-4.96 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	72.27	10,000	722,673	121,017	131 K to 121 K (-7.63 %)
Jun 08 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	58.38	4,000	233,516	27,865	31.9 K to 27.9 K (-12.55 %)
Jun 08 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	57.56	5,000	287,805	131,017	136 K to 131 K (-3.68 %)
Jun 08 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	58.25	5,000	291,260	136,017	141 K to 136 K (-3.55 %)
Jun 03 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	A	50.87	7,000	356,090	7,000
Jun 03 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Grant	A	0.00	1,950	0	141,017	139.1 K to 141 K (+1.40 %)
Jun 17 2015	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	A	59.23	10,000	592,300	10,000

Page: 1